BAMF
GMAB icon

BI Asset Management Fondsmaeglerselskab’s Genmab GMAB Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-88,037
Closed -$3.32M – 765
2023
Q1 		$3.32M Buy
+88,037
New +$3.38M 0.09% 176

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's GMAB Position: Q2 2023 in Review

BI Asset Management Fondsmaeglerselskab sold out of Genmab (GMAB) in Q2 2023, closing a stake of 88,037 shares — an estimated $3.32M sold.

BI Asset Management Fondsmaeglerselskab first reported a position in GMAB in Q1 2023 and held it in 1 quarter. The position peaked at $3.32M in Q1 2023. 214 funds tracked by Wall St. Rank hold GMAB as of Q2 2023.

  • BI Asset Management Fondsmaeglerselskab reported no remaining Genmab position as of Q2 2023 after selling out during the quarter.
  • BI Asset Management Fondsmaeglerselskab sold 88,037 Genmab shares in Q2 2023, an estimated $3.32M.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Genmab in Q1 2023 and held it in 1 quarter.
  • BI Asset Management Fondsmaeglerselskab's Genmab position peaked at $3.32M in Q1 2023.
  • 214 funds tracked by Wall St. Rank held Genmab as of Q2 2023.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2023, filed 3 Aug 2023.